Biomolecules of Adipose Tissue in Atherosclerotic Plaques of Men With Coronary Atherosclerosis [0.03%]
男性冠状动脉粥样硬化患者动脉粥样硬化斑块中脂肪组织的生物分子
E V Garbuzova,Ya V Polonskaya,E V Kashtanova et al.
E V Garbuzova et al.
Aim: To study metabolic molecules (adiponectin, adipsin, resistin, glucagon-like peptide-1 (GLP-1), glucagon, secretin) of adipose tissue in atherosclerotic plaques (AP) and their associations with AP instability in men w...
V L Lakomkin,A A Abramov,A V Prosvirnin et al.
V L Lakomkin et al.
Aim: To study the relaxation structure of the left ventricle (LV) in patients who underwent ventriculography. Material and methods: LV ...
V V Skibitskiy,A V Fendrikova,A V Skibitskiy et al.
V V Skibitskiy et al.
Aim: To compare the efficacy of adding original moxonidine and its generics to previous ineffective antihypertensive therapy in patients with poorly controlled arterial hypertension (AH). ...
Observational Study
Kardiologiia. 2024 Aug 31;64(8):24-31. DOI:10.18087/cardio.2024.8.n2731 2024
Patients With Non-Obstructive Coronary Artery Disease and Polyvascular Disease. Sub-Analysis of the Real-World Registry KAMMA (Clinical Registry on Patient Population With Polyvascular Disease in the Russian Federation and Eurasian Countries) [0.03%]
无阻塞性冠状动脉疾病合并多血管疾病的患者：KAMMA注册研究（俄罗斯联邦和欧亚国家多血管疾病患者人群的临床登记）的亚组分析
G P Arutyunov,E I Tarlovskaya,A G Arutyunov et al.
G P Arutyunov et al.
Aim: To study the clinical status and data of laboratory and instrumental examination of patients with non-obstructive ischemic heart disease (IHD) and multifocal atherosclerosis (MFA) included in the KAMMA registry. ...
Modern Instrumental Methods of Diagnostics and Risk Assessment of Developing Antitumor Therapy Cardiovasculotoxicity [0.03%]
现代抗肿瘤治疗心血管毒性的诊断及风险评估的 instrumental methods
Yu N Belenkov,I S Ilgisonis,N V Khabarova et al.
Yu N Belenkov et al.
The most important component of cardio-oncology is the assessment of the risk of development and diagnosis of cardiovascular toxicity of the antitumor therapy, the detection of which is largely based on visualization of the cardiovascular s...
[A Case of Successful Treatment of Severe Hyperlipidemia After Heart Transplantation With Inclisiran] [0.03%]
依折麦布治疗1例心脏移植术后重度高脂血症患者案例报告
Z G Tatarintseva,L K Tkhatl,K O Barbuhatti et al.
Z G Tatarintseva et al.
The prognosis after heart transplantation continues to improve. Therefore, the prevention of chronic post-transplant sequelae, such as chronic kidney disease, allograft vasculopathy, and malignancies is becoming increasingly important. Ever...
Case Reports
Kardiologiia. 2024 Jul 31;64(7):72-76. DOI:10.18087/cardio.2024.7.n2679 2024
[The effect of sodium-glucose cotransporter type 2 inhibitors on left ventricular diastolic function: current status and prospects] [0.03%]
钠-葡萄糖共转运蛋白2抑制剂对左心室舒张功能的影响：现状与前景
E V Borisova,A V Barsukov,S A Glebova et al.
E V Borisova et al.
Sodium-glucose cotransporter-2 inhibitors (SGLT2 inhibitors) or gliflozins, are a new class of cardiovascular drugs with a proven clinical efficacy and a beneficial effect on prognosis in patients with heart failure with preserved ejection ...
Prevalence, Clinical Features, Treatment, and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Arteries [0.03%]
非梗阻性冠状动脉疾病患者心肌梗死的流行病学、临床特点、治疗及预后
T H Hoang,V V Maiskov,I A Merai et al.
T H Hoang et al.
Aim: To study clinical and demographic characteristics, treatment options, and clinical outcomes in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) compared with patients with myocardia...
Observational Study
Kardiologiia. 2024 Jul 31;64(7):56-63. DOI:10.18087/cardio.2024.7.n2526 2024
Possibilities of Azilsartan Medoxomil for Preparation for Planned Percutaneous Coronary Intervention in Patients With Type 2 Diabetes Mellitus [0.03%]
氯沙坦钾美.major血管造影术前准备的可能性在2型糖尿病患者中的可能性
A M Kochergina,O L Barbarash
A M Kochergina
Aim: To evaluate the efficacy and safety of azilsartan medoxomil for preoperative preparation and improving the long-term prognosis of elective percutaneous coronary intervention (PCI) in patients with ischemic heart dise...
Randomized Controlled Trial
Kardiologiia. 2024 Jul 31;64(7):48-55. DOI:10.18087/cardio.2024.7.n2671 2024
Inflammatory Biomarkers in Patients With Type 2 Diabetes Mellitus and Heart Failure With Preserved Ejection Faction [0.03%]
II型糖尿病合并射血分数保留的心力衰竭患者的炎症生物标志物水平
T S Sveklina,S B Shustov,S N Kolyubaeva et al.
T S Sveklina et al.
Aim: To verify the relationship between gene polymorphisms of tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6) with inflammation markers and codependent metabolic variables in patients with type 2 diabetes me...